Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

  • The following term was not found in PubMed: andanttonen.
  • Showing results for olszak andanttonen. Search instead for bolszak andanttonen (0)
1.

Phage life cycles behind bacterial biodiversity.

Olszak T, Latka A, Roszniowski B, Valvano MA, Drulis-Kawa Z.

Curr Med Chem. 2017 Apr 13. doi: 10.2174/0929867324666170413100136. [Epub ahead of print]

PMID:
28412903
2.

The temperate Burkholderia phage AP3 of the Peduovirinae shows efficient antimicrobial activity against B. cenocepacia of the IIIA lineage.

Roszniowski B, Latka A, Maciejewska B, Vandenheuvel D, Olszak T, Briers Y, Holt GS, Valvano MA, Lavigne R, Smith DL, Drulis-Kawa Z.

Appl Microbiol Biotechnol. 2017 Feb;101(3):1203-1216. doi: 10.1007/s00253-016-7924-7. Epub 2016 Oct 21.

3.

[Ibogaine - structure, influence on human body, clinical relevance].

Zdrojewicz Z, Kuszczak B, Olszak N.

Pol Merkur Lekarski. 2016 Jul 29;41(241):50-55. Review. Polish.

PMID:
27734823
4.

A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections.

Danis-Wlodarczyk K, Vandenheuvel D, Jang HB, Briers Y, Olszak T, Arabski M, Wasik S, Drabik M, Higgins G, Tyrrell J, Harvey BJ, Noben JP, Lavigne R, Drulis-Kawa Z.

Sci Rep. 2016 Jun 15;6:28115. doi: 10.1038/srep28115.

5.

Correction: Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm.

Danis-Wlodarczyk K, Olszak T, Arabski M, Wasik S, Majkowska-Skrobek G, Augustyniak D, Gula G, Briers Y, Jang HB, Vandenheuvel D, Duda KA, Lavigne R, Drulis-Kawa Z.

PLoS One. 2015 Aug 25;10(8):e0137015. doi: 10.1371/journal.pone.0137015. eCollection 2015. No abstract available.

6.

Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.

Schnitzler F, Friedrich M, Stallhofer J, Schönermarck U, Fischereder M, Habicht A, Karbalai N, Wolf C, Angelberger M, Olszak T, Beigel F, Tillack C, Göke B, Zachoval R, Denk G, Guba M, Rust C, Grüner N, Brand S.

PLoS One. 2015 Aug 19;10(8):e0135807. doi: 10.1371/journal.pone.0135807. eCollection 2015.

7.

Phenotypic characterization of an international Pseudomonas aeruginosa reference panel: strains of cystic fibrosis (CF) origin show less in vivo virulence than non-CF strains.

Cullen L, Weiser R, Olszak T, Maldonado RF, Moreira AS, Slachmuylders L, Brackman G, Paunova-Krasteva TS, Zarnowiec P, Czerwonka G, Reilly J, Drevinek P, Kaca W, Melter O, De Soyza A, Perry A, Winstanley C, Stoitsova SR, Lavigne R, Mahenthiralingam E, Sá-Correia I, Coenye T, Drulis-Kawa Z, Augustyniak D, Valvano MA, McClean S.

Microbiology. 2015 Oct;161(10):1961-77. doi: 10.1099/mic.0.000155. Epub 2015 Aug 6.

PMID:
26253522
8.

The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A>C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations.

Schnitzler F, Friedrich M, Wolf C, Stallhofer J, Angelberger M, Diegelmann J, Olszak T, Tillack C, Beigel F, Göke B, Glas J, Lohse P, Brand S.

PLoS One. 2015 Jul 6;10(7):e0116044. doi: 10.1371/journal.pone.0116044. eCollection 2015.

9.

Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm.

Danis-Wlodarczyk K, Olszak T, Arabski M, Wasik S, Majkowska-Skrobek G, Augustyniak D, Gula G, Briers Y, Jang HB, Vandenheuvel D, Duda KA, Lavigne R, Drulis-Kawa Z.

PLoS One. 2015 May 21;10(5):e0127603. doi: 10.1371/journal.pone.0127603. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0137015.

10.

Modern Therapeutic Approaches Against Pseudomonas aeruginosa Infections.

Dorotkiewicz-Jach A, Augustyniak D, Olszak T, Drulis-Kawa Z.

Curr Med Chem. 2015;22(14):1642-64. Review.

PMID:
25882546
11.

In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.

Olszak T, Zarnowiec P, Kaca W, Danis-Wlodarczyk K, Augustyniak D, Drevinek P, de Soyza A, McClean S, Drulis-Kawa Z.

Appl Microbiol Biotechnol. 2015 Jul;99(14):6021-33. doi: 10.1007/s00253-015-6492-6. Epub 2015 Mar 12.

12.

The NOD2 p.Leu1007fsX1008 mutation (rs2066847) is a stronger predictor of the clinical course of Crohn's disease than the FOXO3A intron variant rs12212067.

Schnitzler F, Friedrich M, Wolf C, Angelberger M, Diegelmann J, Olszak T, Beigel F, Tillack C, Stallhofer J, Göke B, Glas J, Lohse P, Brand S.

PLoS One. 2014 Nov 3;9(11):e108503. doi: 10.1371/journal.pone.0108503. eCollection 2014.

13.

Protective mucosal immunity mediated by epithelial CD1d and IL-10.

Olszak T, Neves JF, Dowds CM, Baker K, Glickman J, Davidson NO, Lin CS, Jobin C, Brand S, Sotlar K, Wada K, Katayama K, Nakajima A, Mizuguchi H, Kawasaki K, Nagata K, Müller W, Snapper SB, Schreiber S, Kaser A, Zeissig S, Blumberg RS.

Nature. 2014 May 22;509(7501):497-502. doi: 10.1038/nature13150. Epub 2014 Apr 6.

14.

Involvement of the iNKT cell pathway is associated with early-onset eosinophilic esophagitis and response to allergen avoidance therapy.

Lexmond WS, Neves JF, Nurko S, Olszak T, Exley MA, Blumberg RS, Fiebiger E.

Am J Gastroenterol. 2014 May;109(5):646-57. doi: 10.1038/ajg.2014.12. Epub 2014 Feb 11.

15.

Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells.

An D, Oh SF, Olszak T, Neves JF, Avci FY, Erturk-Hasdemir D, Lu X, Zeissig S, Blumberg RS, Kasper DL.

Cell. 2014 Jan 16;156(1-2):123-33. doi: 10.1016/j.cell.2013.11.042.

16.

Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.

Diegelmann J, Czamara D, Le Bras E, Zimmermann E, Olszak T, Bedynek A, Göke B, Franke A, Glas J, Brand S.

PLoS One. 2013 Nov 5;8(11):e77773. doi: 10.1371/journal.pone.0077773. eCollection 2013.

17.

A giant Pseudomonas phage from Poland.

Drulis-Kawa Z, Olszak T, Danis K, Majkowska-Skrobek G, Ackermann HW.

Arch Virol. 2014 Mar;159(3):567-72. doi: 10.1007/s00705-013-1844-y. Epub 2013 Sep 26.

18.

CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling.

Hosomi S, Chen Z, Baker K, Chen L, Huang YH, Olszak T, Zeissig S, Wang JH, Mandelboim O, Beauchemin N, Lanier LL, Blumberg RS.

Eur J Immunol. 2013 Sep;43(9):2473-83. doi: 10.1002/eji.201242676. Epub 2013 Jun 18.

19.

IRGM variants and susceptibility to inflammatory bowel disease in the German population.

Glas J, Seiderer J, Bues S, Stallhofer J, Fries C, Olszak T, Tsekeri E, Wetzke M, Beigel F, Steib C, Friedrich M, Göke B, Diegelmann J, Czamara D, Brand S.

PLoS One. 2013;8(1):e54338. doi: 10.1371/journal.pone.0054338. Epub 2013 Jan 24.

20.

Analyzing antigen recognition by Natural Killer T cells.

Zeissig S, Olszak T, Melum E, Blumberg RS.

Methods Mol Biol. 2013;960:557-72. doi: 10.1007/978-1-62703-218-6_41.

Supplemental Content

Loading ...
Support Center